Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.
Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.
Insider flow: Net selling by value — a count of disclosed transactions, not a rating or a recommendation.
Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.
Share-weighted average price across 5 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.
One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.
The filings above are public record and stay public here. What an account adds for $PMTS is the reading of them — and for this company, that is what the list below says it is, no more.
A free account opens all of it.
Every open-market transaction disclosed for PMTS in the synced window. Values are the insider's own, as filed.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-14 | Parallel49 Equity, ULC | 10% owner | Open-market sell | 2,687,921 | 20.43 | $54,900,786 |
| 2026-09-14 | Tricor PMT25 Holdings Inc. | 10% owner | Open-market buy | 525,000 | 21.50 | $11,287,500 |
| 2026-09-14 | Riley H Sanford | Director, Other | Open-market buy | 13,953 | 21.50 | $299,990 |
| 2026-09-14 | SHEINBAUM MARC | Director | Open-market buy | 4,651 | 21.50 | $99,996 |
| 2026-09-14 | Peters Nicholas | Director | Open-market buy | 11,628 | 21.50 | $250,002 |
| 2026-09-14 | Mallela Ravi | Director | Open-market buy | 1,000 | 21.50 | $21,500 |
Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.